MODD1
The page describes insulin pump users facing time investment, costs, and complexity, while highlighting benefits like variable basal insulin and simplified bolusing.

Modular Medical's MODD1 is an insulin pump with 300-unit cartridges designed for providers overseeing diabetes care.
modularmedical.comCrawled Nov 13, 2026
The page describes insulin pump users facing time investment, costs, and complexity, while highlighting benefits like variable basal insulin and simplified bolusing.
MODD1 simplifies insulin delivery, replacing manual injections.
MODD1 is designed to revolutionize the approach for providers to oversee patient's diabetes. With a simplified design, patients can now enjoy the benefits of pumping basal / bolus insulin, and providers gain valuable insight into their patient’s diabetes management.
Modular Medical offers careers focused on diabetes care and insulin-dependent patient support.
Modular Medical develops diabetes technology to improve accessibility and health outcomes for users.
The company provides contact forms for inquiries, collaborations, and information requests.
The technology enables seamless data access for diabetes management between users and their healthcare providers.
The company collects personal information voluntarily provided by users when engaging with its services or products.
Modular Medical and Thrivable surveyed over 540 people with diabetes to assess barriers to insulin pump adoption and perceptions of the company’s Pivot™ tubeless patch pump. The three-phase study examines treatment burden and interest in simplified insulin delivery systems. Participants highlight challenges in current therapies and express demand for easier-to-use alternatives.
Modular Medical secures FDA clearance for its **Pivot pump software**, an update for its insulin delivery systems. The approval enables enhanced functionality for diabetes management devices, though specific features remain undisclosed. The company continues expanding its portfolio in wearable medical technology.
Modular Medical has launched its **Pivot tubeless insulin patch pump** in the U.S. following **FDA 510(k) clearance** in April. The device offers a tubeless, patch-based alternative for insulin delivery, targeting patients seeking discreet and continuous diabetes management solutions. The commercial rollout aligns with the company’s expansion plans in the healthcare technology sector.
Modular Medical completes a critical manufacturing milestone for its **Pivot tubeless insulin patch pump**, advancing development ahead of a planned **Q1 2026 launch** contingent on FDA clearance. The device aims to simplify diabetes management by eliminating traditional tubing while maintaining insulin delivery precision. The milestone marks progress toward regulatory submission and commercial readiness.
Modular Medical completes production of over 6,000 **MODD1 cartridges**, a key component for its medical device platform. The company also begins converting its **Pivot** system to integrate these cartridges, expanding its modular drug-delivery capabilities. This milestone follows prior development efforts to enhance flexibility in treatment administration.